These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Methods of evaluation of psychoactive drugs. Bech P Recenti Prog Med; 1989 Dec; 80(12):706-11. PubMed ID: 2697905 [TBL] [Abstract][Full Text] [Related]
23. [Does the duration of medical consultations have an impact on the prescription of psychotropic drugs? Cross-sectional study carried out in general practice on 2,896 procedures]. Kandel O; Ripault A; Jourdain M; Bouche G Rev Prat; 2008 Jun; 58(12 Suppl):19-24. PubMed ID: 18773661 [TBL] [Abstract][Full Text] [Related]
24. Determinants of prescribing of psychoactive drugs by general practitioners. Mant A Med J Aust; 1975 Jun; 1(24):743-9. PubMed ID: 1152751 [TBL] [Abstract][Full Text] [Related]
25. [Therapy of borderline personality disorder]. Steiner S Schweiz Rundsch Med Prax; 1991 Feb; 80(8):163-8. PubMed ID: 2008551 [TBL] [Abstract][Full Text] [Related]
26. [The role of clinical psychiatry in the development of new drugs]. Benkert O; Hippius H Arzneimittelforschung; 1975 Jul; 25(7a):1195-206. PubMed ID: 1242348 [TBL] [Abstract][Full Text] [Related]
27. Direct-to-consumer pharmaceutical advertising: physician and public opinion and potential effects on the physician-patient relationship. Robinson AR; Hohmann KB; Rifkin JI; Topp D; Gilroy CM; Pickard JA; Anderson RJ Arch Intern Med; 2004 Feb; 164(4):427-32. PubMed ID: 14980994 [TBL] [Abstract][Full Text] [Related]
32. [The physician as medication. Relationship effects in pharmaceutical medicine as exemplified by the placebo]. Grob P Schweiz Rundsch Med Prax; 1989 Feb; 78(8):180-5. PubMed ID: 2922512 [TBL] [Abstract][Full Text] [Related]
33. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization]. Santiago-Delefosse M; Cahen F; Coeffin-Driol C Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699 [TBL] [Abstract][Full Text] [Related]
34. Compliance--a joint effort of the patient and his doctor. Feuerstein M; Lieb-Jückstock V; Schnaus H; Springmann E; Weber B; Wunderlich M Epilepsy Res Suppl; 1988; 1():51-6. PubMed ID: 3243268 [TBL] [Abstract][Full Text] [Related]
35. Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolites. Coutts RT; Baker GB Chirality; 1989; 1(2):99-120. PubMed ID: 2701850 [TBL] [Abstract][Full Text] [Related]
37. Psychoactive drug interactions with pharmacotherapy for diabetes. DeVane CL; Markowitz JS Psychopharmacol Bull; 2002; 36(2):40-52. PubMed ID: 12397839 [TBL] [Abstract][Full Text] [Related]
38. Effects of a new psychoactive drug (DU 27716) on different models of rat agonistic behaviour and EEG. Olivier B; Mos J; Van der Poel AM; Krijzer FN; Kruk MR Prog Clin Biol Res; 1984; 169():261-79. PubMed ID: 6542672 [No Abstract] [Full Text] [Related]
39. Attitudes, behaviors, and expectations of men seeking medical treatment for male pattern hair loss: results of a multinational survey. Cash TF Curr Med Res Opin; 2009 Jul; 25(7):1811-20. PubMed ID: 19514838 [TBL] [Abstract][Full Text] [Related]
40. [General practitioners' attitude to prescription of psychopharmaceuticals. Autonomy versus paternalism, education and understanding of disease]. Holm M; Husted J Ugeskr Laeger; 1991 Jul; 153(27):1929-33. PubMed ID: 1858174 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]